AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2017
Apr 10, 2017
29745_dirs_2017-04-10_677617c3-a99e-4b15-9928-84da122cf56c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2017-04-01
Reporting Person: Norton Johna (Senior VP, Global Quality)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 14493 | Direct |
| Common Stock | 361 | Indirect |
| Common Stock | 1574 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Restricted Stock Unit | $ | 2018-11-03 | Common Stock (3133.0) | Direct | |
| Restricted Stock Unit | $ | Common Stock (193.0) | Indirect |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
F2: The Restricted Stock Units vest in three equal annual installments on February 16, 2018, 2019, and 2020.
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29